Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Astec Industries | ASTE | Sep 27, 2024 | 31.70 | +0.99 |
Astera Labs | ALAB | Sep 27, 2024 | 53.52 | -2.25 |
Astrana Health | ASTH | Sep 27, 2024 | 56.53 | +0.61 |
AstraZeneca ADR | AZN | Sep 27, 2024 | 77.62 | -0.72 |
Astria Therapeutics | ATXS | Sep 27, 2024 | 11.14 | +0.18 |
Astronics | ATRO | Sep 27, 2024 | 20.05 | +0.65 |
AstroNova | ALOT | Sep 27, 2024 | 13.14 | +1.15 |
Astrotech | ASTC | Sep 27, 2024 | 8.20 | +0.99 |
Asure Software | ASUR | Sep 27, 2024 | 9.17 | -0.11 |
AT&T | T | Sep 27, 2024 | 21.90 | +1.15 |
AT&T A Pref | T-A | Sep 27, 2024 | 22.68 | +0.22 |
AT&T C Pref | T-C | Sep 27, 2024 | 21.45 | -0.83 |
ATA Creativity Global ADR | AACG | Sep 27, 2024 | 0.73 | +1.08 |
Atai Life Sciences BV | ATAI | Sep 27, 2024 | 1.17 | -1.68 |
Atara Biotherapeutics | ATRA | Sep 27, 2024 | 8.07 | +5.42 |
Atea Pharmaceuticals | AVIR | Sep 27, 2024 | 3.44 | 0.00 |
Aterian | ATER | Sep 27, 2024 | 2.91 | -0.51 |
Athena Technology Acquisition II | ATEK | Sep 27, 2024 | 11.56 | 0.00 |
Athene A Pref | ATH-A | Sep 27, 2024 | 25.25 | +0.60 |
Athene B Pref | ATH-B | Sep 27, 2024 | 22.84 | +0.35 |
Athene C Pref | ATH-C | Sep 27, 2024 | 25.06 | 0.00 |
Athene D Pref | ATH-D | Sep 27, 2024 | 19.50 | -0.20 |
Athene Holding | ATH-E | Sep 27, 2024 | 26.72 | +0.11 |
Athira Pharma | ATHA | Sep 27, 2024 | 0.44 | +6.14 |
Ati Physical Therapy A | ATIP | Sep 27, 2024 | 6.10 | -0.16 |
ATIF Holdings | ATIF | Sep 27, 2024 | 1.00 | -6.04 |
Atkore | ATKR | Sep 27, 2024 | 85.63 | +0.42 |
Atlanta Braves A | BATRA | Sep 27, 2024 | 42.65 | +0.35 |
Atlanta Braves C | BATRK | Sep 27, 2024 | 40.32 | +0.15 |
Atlantic American | AAME | Sep 27, 2024 | 1.68 | +4.35 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.